University of Latvia Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02047994
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Associate Professor and Vice-dean, Institute of Clinical and Preventive Medicine, University of Latvia | University of Latvia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gastritis (Phase 4)

Gastritis, Atrophic (Phase 4)

Stomach Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 5